- SG Blocks (NASDAQ:SGBX) and OSANG Healthcare announced a Managed Supply Agreement building on their distributorship agreement executed earlier this year, to distribute OHC’s "GeneFinder COVID-19 Plus RealAmp Kit" test in the U.S and Canada.
- It is expected that the partnership will enable a much more efficient supply-chain arrangement for OSANG tests, not just for SG Blocks customers but also as a regional distribution hub for pre-existing OSANG customers.
- “OSANG’s FDA approved SARS-CoV-2 test has been used by leading hospitals and other emergency service providers due to its ease-of-use, accuracy and ability to work on low-cost point-of-care analyzers.” stated Paul Galvin, CEO of SG Blocks.